Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's the recommended schedule for lurbinectedin side effect checks?When oxcarbazepine patent expired?Patent expiration eu dabrafenib?Pramlintide fda approval date?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for emsam
EmSam is the brand name for selegiline, a prescription medicine used to treat major depressive disorder (depression) [1]. It belongs to the class of antidepressants known as monoamine oxidase inhibitors (MAOIs) [1].
EmSam works by affecting brain chemicals involved in mood. As an MAOI, selegiline changes how the body breaks down certain neurotransmitters, which can help reduce depressive symptoms [1].
EmSam comes as a transdermal patch (meaning the medicine is delivered through the skin) [1].
The intent of treatment with EmSam is to relieve symptoms of major depressive disorder in eligible patients [1].
Because EmSam is an MAOI, it can have important drug and food interaction risks typical of this drug class. These include the need for careful guidance about what to take alongside it and what to avoid while using it [1].
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
Other Questions About Emsam :